Navigation
Search
|
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
Wednesday April 23, 2025. 11:00 AM , from Wired: Tech.
Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.
https://www.wired.com/story/glp-1-compounding-fda-lawsuits/
Related News |
25 sources
Current Date
Apr, Sat 26 - 05:00 CEST
|